Back
Grand Canyon Education Vs. Nutex Health Industry Stock Comparison
Buy
65
LOPE
Grand Canyon Education
Last Price:
165.98
Seasonality Move:
-0.23%
Buy
58
NUTX
Nutex Health
Last Price:
33.12
Seasonality Move:
-16.36%
Buy
65
Grand Canyon Education (LOPE)
is a Buy
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $168.34. The Score for LOPE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- LOPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Nutex Health (NUTX)
is a Buy
Is Nutex Health a Buy, Sell or Hold?
- The current Nutex Health [NUTX] share price is $32.62. The Score for NUTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NUTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $168.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOPE is experiencing selling pressure, which indicates risk of future bearish movement.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $32.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUTX is experiencing selling pressure, which indicates risk of future bearish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.34 | Buy |
| Relative Strength Index (14 RSI): | 78.9 | Buy |
| Chaikin Money Flow: | -120025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.03 - 156.81) | Buy |
| Bollinger Bands (100): | (134.79 - 151.57) | Buy |
NUTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.83 | Buy |
| Relative Strength Index (14 RSI): | 62.26 | Buy |
| Chaikin Money Flow: | -85516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20 - 28.76) | Buy |
| Bollinger Bands (100): | (8.72 - 24.98) | Buy |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.29 | Buy |
| 20-day SMA: | 144.67 | Buy |
| 50-day SMA: | 141.71 | Buy |
| 200-day SMA: | 139.43 | Buy |
| 8-day EMA: | 161.49 | Buy |
| 20-day EMA: | 150.57 | Buy |
| 50-day EMA: | 144.46 | Buy |
| 200-day EMA: | 138.6 | Buy |
NUTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.14 | Buy |
| 20-day SMA: | 25.59 | Buy |
| 50-day SMA: | 23.17 | Buy |
| 200-day SMA: | 14.02 | Buy |
| 8-day EMA: | 29.96 | Buy |
| 20-day EMA: | 26.54 | Buy |
| 50-day EMA: | 22.9 | Buy |
| 200-day EMA: | 24.52 | Buy |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $0.74 per share.
Nutex Health Earnings Growth & NUTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $1.74 per share.
Grand Canyon Education Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutex Health Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||